@FiercePharma: Genzyme apologizes for latest Fabrazyme delay. News | Follow @FiercePharma
> Pfizer ($PFE) has inked a joint-venture deal with China's Guoyuan to develop and sell animal vaccines in that country. More
> Ipca Laboratories, which owns about one-third of Tinora Pharma, is considering merging the latter company into itself. Piece
> Alkermes ($ALKS) shareholders approved its $960 million acquisition of Elan's drug technologies business. Article
> Bristol-Myers Squibb ($BMY) wrapped up its $325 million-plus-milestones acquisition of Amira, which brings a pipeline of anti-inflammatory drugs. BMS release | Report
> Shire CEO Angus Russell says drugmakers need to pay much closer attention to reimbursement policies and to the comparative data necessary to persuade price-conscious payers to foot the bill for new meds. Story
> Irish distributor Eurodrug was ordered to pay €295,000 in a wrongful dismissal suit filed by its former managing director, Michael Fitzpatrick. Item
> A federal appeals court dismissed two lawsuits challenging the 2010 healthcare reform law, adding to the split decisions that will eventually have to be sorted out. News
Biotech News
@FierceBiotech: Big Pharma VCs may complement traditional venture. Story | Follow @FierceBiotech
@JohnCFierce: Crescendo bioscience (diagnostics) gets $56M in venture cash, myriad debt deal tied to buyout option. Item | Follow @JohnCFierce
@RyanMFierce: Bruce Booth analyzes our shrinking biotech eco system, 27% drop in biopharmas over past 5 years. News | Follow @RyanMFierce
> Analysis: Biotech herd shrinks 27% amid industry upheaval. Item
> J&J's blockbuster hopeful Xarelto bounces back with AdComm backing. News
> GSK's VC unit SR One has new chief. Story
> Dendreon cuts deep into work force to conserve cash. More
And Finally... Federal regulators have punted on potential limits to prescription drugs found in drinking water. Report